Tickwind
TodayOpportunitiesMarketsAI Chat
EN
Log inSign up
Tickwind

Read every tick. See where the market's blowing.

  • X
  • TelegramChinese
  • Newsletter

Product

  • Markets
  • Theme Zones
  • All stocks
  • Compare
  • Hot stocks
  • Opportunities
  • News
  • Discussion
  • Watchlist
  • What's new

Account

  • Settings
  • Newsletter
  • For writers
  • MCP server
  • Contact
  • Log in
  • Sign up
MarketsTheme ZonesAll stocksCompareHot stocksOpportunitiesNewsDiscussionWatchlistWhat's newSettingsNewsletterFor writersMCP serverContactLog inSign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

Home/MRKR/Capital expenditures

MARKER THERAPEUTICS, INC. (MRKR) Capital expenditures 2017–2019

MARKER THERAPEUTICS, INC. (MRKR) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.

$374,983FY2019 · since FY2017: $0 → $374,983
171819
Fiscal yearValueYoY
FY2019$374,983+153.9%
FY2018$147,668—
FY2017$0—

Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.

Source: SEC XBRL filings · For reference only · Not investment advice

More MRKR financial trends

MRKR RevenueMRKR Net incomeMRKR Net marginMRKR Gross profitMRKR Gross marginMRKR Operating incomeMRKR Operating marginMRKR Operating cash flowMRKR Free cash flowMRKR Return on equityMRKR Stock buybacksMRKR Dividends paidMRKR Total assetsMRKR Total liabilitiesMRKR Shareholders’ equityMRKR overview →